Redefining Oncology: Designing Survival as a Core Metric

Technological progress, especially in artificial intelligence, is reshaping healthcare systems with significant effects on oncology. These changes emphasize diagnosing cancer early, customizing treatments, and improving survival outcomes. Moving beyond traditional metrics, health tech innovators are advocating for resilience as a core parameter in the development of therapies. By examining 'exceptional survivors', those who defy survival odds, new insights on resilience can be applied to patient care strategies. This approach encourages proactive survival design, enabling adaptation through tools such as digital twins and wearable technology. Startups and investors are urged to explore solutions that extend beyond treatment, enhancing both longevity and quality of life post-treatment.